BACKGROUND: The main objective of this study was to describe the patients who were hospitalised at Oslo University Hospital Aker during the first wave of pandemic Influenza A (H1N1) in Norway. METHODS: Clinical data on all patients hospitalised with influenza-like illness from July to the end of November 2009 were collected prospectively. Patients with confirmed H1N1 Influenza A were compared to patients with negative H1N1 tests. RESULTS: 182 patients were hospitalised with suspected H1N1 Influenza A and 64 (35%) tested positive. Seventeen patients with positive tests (27%) were admitted to an intensive care unit and four patients died (6%). The H1N1 positive patients were younger, consisted of a higher proportion of non-ethnic Norwegians, had a higher heart rate on admission, and fewer had pre-existing hypertension, compared to the H1N1 negative patients. However, hypertension was the only medical condition that was significantly associated with a more serious outcome defined as ICU admission or death, with a univariate odds ratio of the composite endpoint in H1N1 positive and negative patients of 6.1 (95% CI 1.3-29.3) and 3.2 (95% CI 1.2-8.7), respectively. Chest radiography revealed pneumonia in 24/59 H1N1 positive patients. 63 of 64 H1N1 positive patients received oseltamivir. CONCLUSIONS: The extra burden of hospitalisations was relatively small and we managed to admit all the patients with suspected H1N1 influenza without opening new pandemic isolation wards. The morbidity and mortality were similar to reports from comparable countries. Established hypertension was associated with more severe morbidity and patients with hypertension should be considered candidates for vaccination programs in future pandemics.
BACKGROUND: The main objective of this study was to describe the patients who were hospitalised at Oslo University Hospital Aker during the first wave of pandemic Influenza A (H1N1) in Norway. METHODS: Clinical data on all patients hospitalised with influenza-like illness from July to the end of November 2009 were collected prospectively. Patients with confirmed H1N1Influenza A were compared to patients with negative H1N1 tests. RESULTS: 182 patients were hospitalised with suspected H1N1Influenza A and 64 (35%) tested positive. Seventeen patients with positive tests (27%) were admitted to an intensive care unit and four patients died (6%). The H1N1 positive patients were younger, consisted of a higher proportion of non-ethnic Norwegians, had a higher heart rate on admission, and fewer had pre-existing hypertension, compared to the H1N1 negative patients. However, hypertension was the only medical condition that was significantly associated with a more serious outcome defined as ICU admission or death, with a univariate odds ratio of the composite endpoint in H1N1 positive and negative patients of 6.1 (95% CI 1.3-29.3) and 3.2 (95% CI 1.2-8.7), respectively. Chest radiography revealed pneumonia in 24/59 H1N1 positive patients. 63 of 64 H1N1 positive patients received oseltamivir. CONCLUSIONS: The extra burden of hospitalisations was relatively small and we managed to admit all the patients with suspected H1N1influenza without opening new pandemic isolation wards. The morbidity and mortality were similar to reports from comparable countries. Established hypertension was associated with more severe morbidity and patients with hypertension should be considered candidates for vaccination programs in future pandemics.
Authors: Germán Fajardo-Dolci; Rafael Gutierrez-Vega; Heberto Arboleya-Casanova; Aremis Villalobos; Kate S Wilson; Sandra G García; Julio Sotelo; José A Córdova Villalobos; Claudia Díaz-Olavarrieta Journal: Thorax Date: 2010-06 Impact factor: 9.139
Authors: Steven A R Webb; Ville Pettilä; Ian Seppelt; Rinaldo Bellomo; Michael Bailey; David J Cooper; Michelle Cretikos; Andrew R Davies; Simon Finfer; Peter W J Harrigan; Graeme K Hart; Belinda Howe; Jonathan R Iredell; Colin McArthur; Imogen Mitchell; Siouxzy Morrison; Alistair D Nichol; David L Paterson; Sandra Peake; Brent Richards; Dianne Stephens; Andrew Turner; Michael Yung Journal: N Engl J Med Date: 2009-10-08 Impact factor: 91.245
Authors: Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli Journal: N Engl J Med Date: 2009-10-08 Impact factor: 91.245
Authors: C L Ward; M H Dempsey; C J A Ring; R E Kempson; L Zhang; D Gor; B W Snowden; M Tisdale Journal: J Clin Virol Date: 2004-03 Impact factor: 3.168
Authors: S Bauernfeind; T Bruennler; B Ehrenstein; J Langgartner; J J Wenzel; S Werner; M Lubnow; T Mueller; B Floerchinger; B Salzberger Journal: Infection Date: 2012-08-11 Impact factor: 3.553
Authors: Fernando González-Candelas; Jenaro Astray; Jordi Alonso; Ady Castro; Rafael Cantón; Juan Carlos Galán; Olatz Garin; Marc Sáez; Nuria Soldevila; Maretva Baricot; Jesús Castilla; Pere Godoy; Miguel Delgado-Rodríguez; Vicente Martín; José María Mayoral; Tomás Pumarola; José María Quintana; Sonia Tamames; Angela Domínguez Journal: PLoS One Date: 2012-03-07 Impact factor: 3.240
Authors: Arvydas Ambrozaitis; Daiva Radzišauskienė; Kęstutis Žagminas; Nerija Kuprevičienė; Stefan Gravenstein; Ligita Jančorienė Journal: Open Med (Wars) Date: 2016-10-07
Authors: Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland Journal: PLoS One Date: 2015-11-25 Impact factor: 3.240